Benjamin L. Palleiko, CHIEF EXECUTIVE OFFICER at KalVista Pharmaceuticals, Inc. (KALV), sold 19,998 shares at $11.88 ($238K) on 2025-05-22, disclosed to the SEC on 2025-05-23.
Open-market sale of $238k KALV by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.88 | 9,999 | $119K | 50.0% |
| 2 | $11.88 | 9,999 | $119K | 50.0% |
| Total | $11.88 avg | 19,998 | $238K | 100% |
| Filing → |
| KALV | SELL | 2026-05-13 | $89K | — | Filing → |
| KALV | SELL | 2026-04-20 | $193K | — | Filing → |
| KALV | SELL | 2026-03-10 | $108K | — | Filing → |